tracken
Bayer Aktie News
Positiv
Reuters
●
5 Tage alt
President Donald Trump's administration urged the U.S. Supreme Court on Monday to take up Bayer's bid to curtail thousands of lawsuits claiming its Roundup weedkiller causes cancer, backing the company's argument that federal law bars the claims.
Neutral
Business Wire
●
5 Tage alt
LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer is pleased the Solicitor General supports U. S. Supreme Court review of the petition for a writ of certiorari in the Durnell case and agrees with the company's arguments on preemption. The company believes that the backing of the U.S. government will be important to the Court's consideration of its petition. The split among federal circuit courts in t...
AD HOC NEWS
●
5 Tage alt
FRANKFURT - Gute Nachrichten zum langwierigen US-Glyphosat-Rechtsstreit von Bayer DE000BAY0017 haben am Dienstagvormittag am Aktienmarkt für Begeisterung gesorgt.
AD HOC NEWS
●
5 Tage alt
(Kurse zum Handelsstart, neue Stimmen)FRANKFURT - Gute Nachrichten zum langwierigen US-Glyphosat-Rechtsstreit von Bayer DE000BAY0017 haben am Dienstagmorgen am Aktienmarkt für Begeisterung gesorgt.
Neutral
Business Wire
●
6 Tage alt
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent presentations to include single-dose vials in addition to the previously cleared Imaging Bulk Package (IBP) presentations for Ultravist® (iopromide), Isovue® (iopami...
AD HOC NEWS
●
10 Tage alt
Die US-Investmentbank Goldman Sachs hat das Kursziel für Bayer DE000BAY0017 von 34,50 auf 38,50 Euro angehoben und die Einstufung auf "Buy" belassen.
Positiv
Invezz
●
13 Tage alt
Bayer shares surged on Monday after the company reported encouraging late-stage clinical trial results for its experimental cardiovascular drug asundexian, offering a rare boost for a pharmaceutical division that has struggled with setbacks and mounting litigation costs. The stock rose more than 9% and traded at €30.30—its highest level in over a week.
Positiv
Market Watch
●
13 Tage alt
Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
